• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

燕麦摄入可降低轻度或临界高血压患者的收缩压和舒张压:一项试点试验。

Oat ingestion reduces systolic and diastolic blood pressure in patients with mild or borderline hypertension: a pilot trial.

作者信息

Keenan Joseph M, Pins Joel J, Frazel Christina, Moran Antoinette, Turnquist Lisa

出版信息

J Fam Pract. 2002 Apr;51(4):369.

PMID:11978262
Abstract

OBJECTIVES

We assessed the short-term antihypertensive effects of soluble fiber-rich whole oat cereals when added to a standard American diet. In addition, multiple assessments of insulin sensitivity were conducted.

STUDY DESIGN

This was a randomized, controlled, parallel-group pilot study designed to compare an oat cereal group (standardized to 5.52 g/day beta-glucan) to a low-fiber cereal control group (less than 1.0 g/day total fiber) over 6 weeks.

POPULATION

A total of 18 hypertensive and hyperinsulinemic (= 10 U/mL or more) men and women completed the trial.

OUTCOMES MEASURED

Primary study outcomes were changes in systolic blood pressure (SBP) and diastolic blood pressure (DBP). Secondary outcomes included blood lipid, fasting glucose, and insulin levels and side effects related to elevated blood pressure and increased dietary fiber intake.

RESULTS

The oat cereal group experienced a 7.5 mm Hg reduction in SBP (P &lt.01) and a 5.5 mm Hg reduction in DBP (P &lt.02), while there was virtually no change in either SBP or DBP in the control group. In the oat cereal group, a trend was observed for a lower total insulin response to a glucose load, suggesting improved insulin sensitivity. However, this could not be confirmed using estimates from the Bergman Minimal Model, perhaps because of our small sample size. The oats group experienced a significant reduction in both total cholesterol (9%) and low-density lipoprotein cholesterol (14%).

CONCLUSIONS

The addition of oat cereals to the normal diet of patients with hypertension significantly reduces both SBP and DBP. Soluble fiber-rich whole oats may be an effective dietary therapy in the prevention and adjunct treatment of hypertension.

摘要

目的

我们评估了富含可溶性纤维的全燕麦谷物添加到标准美国饮食中的短期降压效果。此外,还对胰岛素敏感性进行了多项评估。

研究设计

这是一项随机、对照、平行组的试点研究,旨在比较燕麦谷物组(标准化为每天5.52克β-葡聚糖)和低纤维谷物对照组(每天总纤维少于1.0克),为期6周。

研究对象

共有18名高血压和高胰岛素血症(=10 U/mL或更高)的男性和女性完成了试验。

测量的结果

主要研究结果是收缩压(SBP)和舒张压(DBP)的变化。次要结果包括血脂、空腹血糖和胰岛素水平,以及与血压升高和膳食纤维摄入量增加相关的副作用。

结果

燕麦谷物组的SBP降低了7.5 mmHg(P<0.01),DBP降低了5.5 mmHg(P<0.02),而对照组的SBP和DBP几乎没有变化。在燕麦谷物组中,观察到对葡萄糖负荷的总胰岛素反应有降低的趋势,表明胰岛素敏感性有所改善。然而,使用伯格曼最小模型的估计无法证实这一点,可能是因为我们的样本量较小。燕麦组的总胆固醇(9%)和低密度脂蛋白胆固醇(14%)均显著降低。

结论

在高血压患者的正常饮食中添加燕麦谷物可显著降低SBP和DBP。富含可溶性纤维的全燕麦可能是预防和辅助治疗高血压的有效饮食疗法。

相似文献

1
Oat ingestion reduces systolic and diastolic blood pressure in patients with mild or borderline hypertension: a pilot trial.燕麦摄入可降低轻度或临界高血压患者的收缩压和舒张压:一项试点试验。
J Fam Pract. 2002 Apr;51(4):369.
2
Do whole-grain oat cereals reduce the need for antihypertensive medications and improve blood pressure control?全谷物燕麦片能否减少抗高血压药物的使用需求并改善血压控制?
J Fam Pract. 2002 Apr;51(4):353-9.
3
Oat bran concentrate bread products improve long-term control of diabetes: a pilot study.燕麦麸浓缩物面包产品改善糖尿病的长期控制:一项试点研究。
J Am Diet Assoc. 1996 Dec;96(12):1254-61. doi: 10.1016/S0002-8223(96)00329-X.
4
Effects of consuming foods containing oat beta-glucan on blood pressure, carbohydrate metabolism and biomarkers of oxidative stress in men and women with elevated blood pressure.食用含燕麦β-葡聚糖的食物对血压升高的男性和女性的血压、碳水化合物代谢及氧化应激生物标志物的影响。
Eur J Clin Nutr. 2007 Jun;61(6):786-95. doi: 10.1038/sj.ejcn.1602562. Epub 2006 Dec 6.
5
Oat beta-glucan reduces blood cholesterol concentration in hypercholesterolemic subjects.燕麦β-葡聚糖可降低高胆固醇血症患者的血液胆固醇浓度。
Eur J Clin Nutr. 1994 Jul;48(7):465-74.
6
Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.缬沙坦联合氢氯噻嗪与氨氯地平单药治疗对伴有其他心血管危险因素的高血压患者的疗效及耐受性比较:VAST研究
Clin Ther. 2005 May;27(5):578-87. doi: 10.1016/j.clinthera.2005.05.006.
7
Effect of soluble fiber intake in lipid and glucose levels in healthy subjects: a randomized clinical trial.可溶性纤维摄入量对健康受试者血脂和血糖水平的影响:一项随机临床试验。
Diabetes Res Clin Pract. 2004 Jul;65(1):7-11. doi: 10.1016/j.diabres.2003.11.005.
8
Oat-derived beta-glucan significantly improves HDLC and diminishes LDLC and non-HDL cholesterol in overweight individuals with mild hypercholesterolemia.燕麦来源的β-葡聚糖可显著提高轻度高胆固醇血症超重个体的高密度脂蛋白胆固醇(HDLC)水平,并降低低密度脂蛋白胆固醇(LDLC)和非高密度脂蛋白胆固醇水平。
Am J Ther. 2007 Mar-Apr;14(2):203-12. doi: 10.1097/01.pap.0000249917.96509.e7.
9
Can guava fruit intake decrease blood pressure and blood lipids?摄入番石榴果实能降低血压和血脂吗?
J Hum Hypertens. 1993 Feb;7(1):33-8.
10
Efficacy and safety comparative evaluation of orlistat and sibutramine treatment in hypertensive obese patients.奥利司他与西布曲明治疗高血压肥胖患者的疗效与安全性对比评估
Diabetes Obes Metab. 2005 Jan;7(1):47-55. doi: 10.1111/j.1463-1326.2004.00372.x.

引用本文的文献

1
Genome-wide association studies reveal genetic control of nutritional quality, milling traits, and agronomic characteristics in oat (Avena sativa L.).全基因组关联研究揭示了燕麦(Avena sativa L.)营养品质、碾磨特性和农艺性状的遗传控制。
Plant Genome. 2025 Sep;18(3):e70060. doi: 10.1002/tpg2.70060.
2
The Role of Intestinal Microbiota and Dietary Fibre in the Regulation of Blood Pressure Through the Interaction with Sodium: A Narrative Review.肠道微生物群和膳食纤维通过与钠的相互作用在血压调节中的作用:一项叙述性综述。
Microorganisms. 2025 May 30;13(6):1269. doi: 10.3390/microorganisms13061269.
3
Dietary Supplements Containing Oat Beta-Glucan and/or Green Coffee (Poly)phenols Showed Limited Effect in Modulating Cardiometabolic Risk Biomarkers in Overweight/Obese Patients without a Lifestyle Intervention.
含有燕麦β-葡聚糖和/或绿咖啡(多)酚的膳食补充剂在不进行生活方式干预的超重/肥胖患者中调节心血管代谢风险生物标志物的效果有限。
Nutrients. 2023 May 8;15(9):2223. doi: 10.3390/nu15092223.
4
Effects of Four Different Dietary Fibre Supplements on Weight Loss and Lipid and Glucose Serum Profiles during Energy Restriction in Patients with Traits of Metabolic Syndrome: A Comparative, Randomized, Placebo-Controlled Study.四种不同膳食纤维补充剂对代谢综合征特征患者能量限制期间体重减轻及血脂和血糖血清指标的影响:一项比较、随机、安慰剂对照研究
Foods. 2023 May 24;12(11):2122. doi: 10.3390/foods12112122.
5
Fiber-enriched botanicals: A therapeutic tool against certain metabolic ailments.富含纤维的植物性物质:对抗某些代谢性疾病的治疗工具。
Food Sci Nutr. 2022 Aug 26;10(10):3203-3218. doi: 10.1002/fsn3.2920. eCollection 2022 Oct.
6
Bioactive components in Bambara groundnut ( Verdc) as a potential source of nutraceutical ingredients.作为营养保健成分潜在来源的 Bambara 花生(Verdc)中的生物活性成分。
Heliyon. 2022 Feb 26;8(3):e09024. doi: 10.1016/j.heliyon.2022.e09024. eCollection 2022 Mar.
7
Effect of oat supplementation interventions on cardiovascular disease risk markers: a systematic review and meta-analysis of randomized controlled trials.燕麦补充干预对心血管疾病风险标志物的影响:一项随机对照试验的系统评价和荟萃分析。
Eur J Nutr. 2022 Jun;61(4):1749-1778. doi: 10.1007/s00394-021-02763-1. Epub 2022 Jan 3.
8
A Review of Health-Beneficial Properties of Oats.燕麦对健康有益特性的综述
Foods. 2021 Oct 26;10(11):2591. doi: 10.3390/foods10112591.
9
Oat Intake and Risk of Type 2 Diabetes, Cardiovascular Disease and All-Cause Mortality: A Systematic Review and Meta-Analysis.燕麦摄入与 2 型糖尿病、心血管疾病和全因死亡率风险:系统评价和荟萃分析。
Nutrients. 2021 Jul 26;13(8):2560. doi: 10.3390/nu13082560.
10
Influence of Dietary Components and Traditional Chinese Medicine on Hypertension: A Potential Role for Gut Microbiota.饮食成分和中药对高血压的影响:肠道微生物群的潜在作用
Evid Based Complement Alternat Med. 2021 Apr 20;2021:5563073. doi: 10.1155/2021/5563073. eCollection 2021.